Cargando…
Molecular Targeting of Cancer-Associated PCNA Interactions in Pancreatic Ductal Adenocarcinoma Using a Cell-Penetrating Peptide
Pancreatic ductal adenocarcinoma is a particularly difficult cancer to treat due to a lack of effective screening or treatment. Pancreatic cancer cells exhibit high proliferating cell nuclear antigen (PCNA) expression, which is associated with poor prognosis. PCNA, an important nuclear DNA replicati...
Autores principales: | Smith, Shanna J., Li, Caroline M., Lingeman, Robert G., Hickey, Robert J., Liu, Yilun, Malkas, Linda H., Raoof, Mustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190754/ https://www.ncbi.nlm.nih.gov/pubmed/32368614 http://dx.doi.org/10.1016/j.omto.2020.03.025 |
Ejemplares similares
-
A PCNA-Derived Cell Permeable Peptide Selectively Inhibits Neuroblastoma Cell Growth
por: Gu, Long, et al.
Publicado: (2014) -
The Mechanism by Which MYCN Amplification Confers an Enhanced Sensitivity to a PCNA-Derived Cell Permeable Peptide in Neuroblastoma Cells
por: Gu, Long, et al.
Publicado: (2015) -
Novel Peptide Therapeutic Approaches for Cancer Treatment
por: Li, Caroline M., et al.
Publicado: (2021) -
Partial Purification of a Megadalton DNA Replication Complex by Free Flow Electrophoresis
por: Li, Caroline M., et al.
Publicado: (2016) -
A cell permeable bimane-constrained PCNA-interacting peptide
por: Horsfall, Aimee J., et al.
Publicado: (2021)